Who Paid My Doc
Ribfix Blu Advantage
Device CMF & Thoracic
PDI 00888233039567
General payments
$2,338,018
Research payments
$41,660
Through program year 2025, $2,338,018 in general payments and $41,660 in research payments were reported against Ribfix Blu Advantage (CMF & Thoracic).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $473,681 | 687 |
| 2024 | General | $551,751 | 826 |
| 2024 | Research | $6,820 | 7 |
| 2023 | General | $685,388 | 955 |
| 2023 | Research | $34,840 | 3 |
| 2022 | General | $627,197 | 856 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 19 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 35 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
3,324 general · 10 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.